Dianthus Therapeutics, Inc.
DNTH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001690585
In the last 90 days, Dianthus Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 269 institutions reported holding it in 13F filings for Q2 2026, worth $6.40B in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Dianthus Therapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 94
- +1 vs. Q3 2021
- Shares held
- 47.7M
- +9.81M (+25.9%) vs. Q3 2021
- Total value
- $211.4M
- −$64.6M (−23.4%) vs. Q3 2021
- New holders
- 17
- 26 more added
- Sold out
- 16
- 20 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DNTH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 269 | $6.40B |
| Q1 2026 | 241 | $5.18B |
| Q4 2025 | 166 | $2.02B |
| Q3 2025 | 140 | $1.84B |
| Q2 2025 | 103 | $728.6M |
| Q1 2025 | 99 | $685.5M |
| Q4 2024 | 96 | $765.7M |
| Q3 2024 | 91 | $858.7M |
| Q2 2024 | 74 | $768.8M |
| Q1 2024 | 76 | $782.3M |
| Q4 2023 | 39 | $106.5M |
| Q3 2023 | 30 | $136.3M |
| Q2 2023 | 46 | $22.0M |
| Q1 2023 | 52 | $23.6M |
| Q4 2022 | 54 | $11.1M |
| Q3 2022 | 72 | $65.8M |
| Q2 2022 | 75 | $54.6M |
| Q1 2022 | 93 | $138.9M |
| Q4 2021 | 94 | $211.4M |
| Q3 2021 | 93 | $276.0M |
| Q2 2021 | 97 | $366.3M |
| Q1 2021 | 90 | $418.4M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Dianthus Therapeutics, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −19,715−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −18,703−100.0% | Sold out |
| Aries Wealth Management | 0 | $0 | 0.00% | −18,000−100.0% | Sold out |
| Evoke Wealth, LLC | 0 | $0 | 0.00% | −18,100−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −15,395−100.0% | Sold out |
| Parametric Portfolio Associates LLC | 0 | $0 | 0.00% | −15,205−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −15,029−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −14,639−100.0% | Sold out |
| Penserra Capital Management LLC | 0 | $0 | 0.00% | −1,335−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −79−100.0% | Sold out |